Kolexia
Bardou-Jacquet Edouard Gastro-entérologie
Bardou-Jacquet Edouard
Gastro-entérologie
Hôpital Pontchaillou
Rennes, France
140 Activités
204 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémochromatose Surcharge en fer Fibrose Maladies du foie Cirrhose du foie Carcinome hépatocellulaire Stéatose hépatique Tumeurs du foie Hépatite

Collaborateurs

Voir plus
Deugnier Yves
Deugnier Yves
Hôpital Pontchaillou, Rennes, France
Laine Fabrice
Laine Fabrice
Hôpital Pontchaillou, Rennes, France
Jezequel Caroline
Jezequel Caroline
Hôpital Pontchaillou, Rennes, France
Loreal Olivier
Loreal Olivier
CHU Rennes, Rennes, France

Industries

Voir plus
Gilead
10 collaboration(s)
Dernière en 2023
Abbvie
7 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
6 collaboration(s)
Dernière en 2020
ORPHALAN SAS
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis
Essai Clinique (Takeda Pharmaceutical)   14 mars 2024
ProPILARifax: A Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial Comparing Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites : Using or Not Using Rifaximin
Essai Clinique (CHU Besançon)   04 mars 2024
NATiV3: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
Essai Clinique (Inventiva Pharma)   24 janvier 2024
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia.
Nature reviews. Endocrinology   14 décembre 2023
Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
European radiology   04 juillet 2023
Nirmatrelvir/ritonavir: Efficacy, safety and drug monitoring in a real-life cohort of outpatient liver transplant recipients
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
FIBR-OH: Interest of Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Didease in Alcoholic Patients in Weaning.
Essai Clinique (CHU Rennes)   19 mai 2023
Artificial Intelligence-Based Opportunities in Liver Pathology-A Systematic Review.
Diagnostics (Basel, Switzerland)   19 mai 2023
Non-invasive diagnosis of alcohol-related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography.
Alimentary pharmacology & therapeutics   20 avril 2023
Traitement médical de la stéatohépatite métabolique en 2022
Nutrition Clinique et Métabolisme   28 mars 2023